Personalization of Cover Letter and Response Rate

计划入组 25,000 人 · 首次发布于 2017 年 2 月 8 日

TNT to Increase the Clinical Complete Response Rate for Distal LARC

计划入组 98 人 · 首次发布于 2019 年 2 月 15 日

Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia

计划入组 148 人 · 首次发布于 2014 年 11 月 21 日

Digoxin(Digox, Lanoxin)

C₄₁H₆₄O₁₄ · Rx

RDX-002,Response

RDX-002(Response Pharmaceuticals)

Response Biomedical Corp.

Canada

Immune Response Biopharma, Inc.

United States

Allarity Therapeutics

United States

Imugene Reports 75% Response Rate in Diffuse Large B-Cell Lymphoma Trial

Novel BTK Degrader BGB-16673 Achieves 84.8% Response Rate in Heavily Pretreated CLL/SLL Patients

Novel BTK Degrader BGB-16673 Demonstrates 85% Response Rate in Heavily Pretreated CLL/SLL Patients